Showing results (1-10 of 218) with videos related to
Sort By:
Pageof 22
Obstetrics and Gynecology|November 11, 2022
Endometrial HyperplasiaKari L Ring, Anne M Mills, Susan C ModesittObstetrics and Gynecology Clinics of North America|February 12, 2018
Hereditary Cancers in Gynecology: What Physicians Should Know About Genetic Testing, Screening, and Risk ReductionKari L Ring, Susan C ModesittThe American Journal of Surgical Pathology|December 17, 2016
PD-L1 Expression in Mismatch Repair-deficient Endometrial Carcinomas, Including Lynch Syndrome-associated and MLH1 Promoter Hypermethylated TumorsEmily A Sloan, Kari L Ring, Brian C Willis, et al.Human Pathology|July 1, 2018
Clinicopathologic characterization of breast carcinomas in patients with non-BRCA germline mutations: results from a single institution's high-risk populationAlice E Meiss, Martha Thomas, Susan C Modesitt, et al.International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 12, 2021
MLH1/PMS2-deficient Endometrial Carcinomas in a Universally Screened Population: MLH1 Hypermethylation and Germline Mutation StatusBrett Kurpiel, Martha S Thomas, Mansoor Mubeen, et al.American Journal of Obstetrics and Gynecology|April 16, 2017
Current and future role of genetic screening in gynecologic malignanciesKari L Ring, Christine Garcia, Martha H Thomas, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 31, 2019
TIM-3 in endometrial carcinomas: an immunotherapeutic target expressed by mismatch repair-deficient and intact cancersMargaret Moore, Kari L Ring, Anne M MillsModern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 22, 2018
Indoleamine 2,3-dioxygenase in endometrial cancer: a targetable mechanism of immune resistance in mismatch repair-deficient and intact endometrial carcinomasAnne Mills, Sara Zadeh, Emily Sloan, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 8, 2021
Targeting immune checkpoints in gynecologic cancer: updates & perspectives for pathologistsAnne M Mills, Tim N Bullock, Kari L RingInternational Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 9, 2020
LAG-3 and GAL-3 in Endometrial Carcinoma: Emerging Candidates for ImmunotherapyLisa A Friedman, Kari L Ring, Anne M MillsPageof 22